- Home
- CARR vs TAK Comparison
CARR vs TAK Comparison
Compare CARR & TAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CARR | TAK |
|---|---|---|
| Founded | 2019 | 1781 |
| Country | United States | Japan |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.3B | 43.3B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | CARR | TAK |
|---|---|---|
| Price | $63.58 | $18.78 |
| Analyst Decision | Buy | |
| Analyst Count | 13 | 0 |
| Target Price | ★ $72.75 | N/A |
| AVG Volume (30 Days) | ★ 8.5M | 3.1M |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | 1.50% | ★ 2.83% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.72 | N/A |
| Revenue | ★ $21,747,000,000.00 | N/A |
| Revenue This Year | $3.56 | N/A |
| Revenue Next Year | $5.24 | $0.95 |
| P/E Ratio | ★ $37.29 | $41.25 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $50.24 | $12.99 |
| 52 Week High | $81.09 | $18.79 |
Technical Indicators
Market Signals| Indicator | CARR | TAK |
|---|---|---|
| Relative Strength Index (RSI) | 57.58 | 79.26 |
| Support Level | $59.21 | $14.78 |
| Resistance Level | $68.20 | N/A |
| Average True Range (ATR) | 2.05 | 0.20 |
| MACD | -0.30 | 0.02 |
| Stochastic Oscillator | 43.39 | 98.65 |
Price Performance
Historical ComparisonAbout CARR Carrier Global Corporation
Carrier Global provides HVAC and refrigeration products and services that serve the global residential, commercial, and transportation markets. The company's HVAC businesses account for approximately 85% of consolidated revenue, with residential and light commercial HVAC and commercial HVAC representing about 60% and 25% of total revenue, respectively. Carrier's refrigeration segment, which accounts for approximately 15% of consolidated revenue, consists of its transportation refrigeration and Sensitech supply chain monitoring products and services.
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.